A County Durham woman who has been battling ovarian cancer for more than five years has become the first in the UK to benefit from a new drug to prevent a recurrence of the disease. The 46-year-old, who does not want to be named, is a patient of Dr Talal Mansy, a consultant medical oncologist at The James Cook University Hospital in Middlesbrough.
News tagged research and development
A determined grandad who is battling prostate cancer has spoken of his joy at joining Jeff Stelling on his March for Men walk – and vowed to get involved with the event again next year. Roofer Ken Bashford, 60, of New Marske, walked with Jeff Stelling and other Prostate Cancer UK fundraisers from Middlesbrough FC’s Riverside Stadium to the Transporter Bridge, as part of Sky Soccer Saturday anchor’s effort to complete 15 marathons in 15 days, taking in 40 football stadiums across the country, from Exeter City FC to Newcastle United.
When self-employed roofer and proud grandad Ken Bashford received an email from Prostate Cancer UK inviting him to take part in local celebrity Jeff Stelling’s latest marathon effort to fight the disease, he was “over the moon”. It was a much-welcomed high point in what has been a rollercoaster ride for the 60-year-old, from Marske, since being diagnosed with prostate cancer himself following a simple blood test in May 2015.
Pancreatic Cancer UK is encouraging people with advanced pancreatic cancer in Middlesbrough to find out more about a pioneering clinical trial at The James Cook University Hospital, which is offering a new combination of treatments which could ultimately allow patients to live for longer. The new HALO 301 trial could offer patients with pancreatic cancer that has spread outside the pancreas, a potential new treatment option for a disease which currently has very few treatments.
A successful project to provide intravenous (IV) antibiotics to patients with a long-term lung condition in their own homes is set to benefit dozens of others with different health conditions. The cutting-edge service improvement enterprise looked at how providing IV antibiotic therapy to patients in their own homes rather than as inpatients in hospital could improve both the patient experience and also reduce costs.